adenoviru
serotyp
likelihood
develop
effect
vaccin
low
describ
inhibitor
adenoviru
proteinas
avp
ultim
object
develop
antiadenoviru
agent
inhibitor
identifi
via
structurebas
drug
design
use
druggabl
site
activ
site
conserv
cofactor
pocket
crystal
structur
avp
lead
compound
identifi
ic
one
eight
structur
deriv
lead
compound
ic
nm
avp
ic
nm
avp
cofactor
bound
adenovirus
major
human
pathogen
infect
wide
rang
vertebr
hamster
human
caus
mani
differ
acut
infect
mostli
respiratori
gastrointestin
tract
conjunct
http
wwwvmrihuharrach
advtaxlonghtm
late
adenoviru
infect
young
virion
assembl
part
precursor
protein
major
virion
protein
precursor
protein
penultim
step
appear
infecti
viru
activ
adenoviru
proteinas
avp
kda
cystein
proteinas
follow
process
virion
precursor
protein
avp
activ
two
cofactor
pvic
gvqslkrrrcf
acid
peptid
cterminu
precursor
protein
vi
pvi
viral
dna
genom
determin
crystal
structur
avppvic
complex
resolut
avp
absenc
cofactor
resolut
avp
essenti
synthesi
infecti
viru
attract
target
antivir
therapi
approach
toward
develop
antivir
agent
adenoviru
specif
inhibitor
avp
use
crystal
structur
dock
program
chemic
portion
open
chemic
repositori
nci
development
therapeut
program
identifi
compound
predict
bind
site
like
critic
avp
activ
report
identifi
analyz
lead
compound
two
deriv
inhibit
enzym
xray
crystal
structur
structur
activ
coval
avppvic
complex
pdb
id
structur
avp
alon
pdb
id
use
silico
screen
prepar
structur
site
identif
water
heteroatom
remov
coordin
file
use
chimera
ucsf
file
gener
util
highest
occup
altern
conform
side
chain
hydrogen
assign
base
default
charg
paramet
hydrogen
strip
structur
dm
modul
chimera
use
gener
molecular
surfac
protein
order
identifi
potenti
site
surfac
sphgen
modul
dock
version
ucsf
run
use
probe
molecular
surfac
result
sphere
file
convert
pdb
format
util
dock
modul
showspher
visual
inspect
sphere
complementar
region
structur
involv
cofactor
bind
activ
carri
sphere
cluster
resid
within
radiu
specif
region
interest
compil
one
cluster
near
activ
site
residu
anoth
cluster
surfac
pocket
avppvic
structur
contain
pvic
term
ntpocket
independ
valid
site
choic
fpocket
open
sourc
pocket
detect
softwar
packag
use
detect
caviti
pdb
file
water
heteroatom
avp
avppvic
complex
remov
visual
inspect
result
queri
structur
embed
center
pocket
sphere
reveal
avp
structur
ntpocket
second
rank
among
identifi
fpocket
analysi
avppvic
structur
result
list
activ
site
pocket
highest
rank
pocket
identifi
fpocket
analysi
fpocket
result
confirm
target
choic
showbox
modul
dock
use
gener
box
direct
around
sphere
cluster
file
use
input
grid
program
calcul
save
inform
concern
steric
electrostat
environ
within
box
area
file
dock
use
screen
approxim
small
molecul
nation
cancer
institutedevelopment
therapeut
program
nci
dtp
open
chemic
repositori
http
dtpcancergov
within
grid
use
select
sphere
theoret
bind
site
small
molecul
output
rank
base
intermolecular
amber
energi
score
van
der
waal
plu
coulomb
contact
score
bump
filter
result
ligand
pose
rank
energi
score
entir
virtual
librari
rel
basi
top
rank
ligand
visual
inspect
bind
pose
target
top
compound
target
obtain
ncidtp
test
efficaci
inhibitor
biochem
assay
gene
adenoviru
serotyp
proteinas
avp
express
escherichia
coli
result
protein
purifi
describ
previous
pvic
gvqslkrrrcf
purchas
invitrogen
carlsbad
ca
pvic
concentr
determin
titrat
cystein
residu
ellman
reagent
use
extinct
coeffici
cm
nm
releas
thionitrobenzo
tpcktreat
trypsin
obtain
worthington
biochem
corpor
papain
obtain
sigma
chemic
compani
nci
compound
obtain
upon
request
http
dtpcancergov
ddm
ndodecyl
dmaltopyranosid
obtain
anatrac
fluorogen
substrat
cbzleuargglyglynh
rhodamin
proargnh
rhodamin
pheargnh
rhodamin
synthes
describ
disulfidelink
avppvic
complex
prepar
overnight
incub
avp
pvic
mm
trishcl
ph
mm
nacl
mm
edta
mm
mercaptoethanol
condit
avp
pvic
undergo
oxid
condens
enzymat
assay
perform
corn
halfarea
black
flat
bottom
plate
reaction
volum
ul
rhodaminebas
fluorogen
substrat
use
excit
emiss
wavelength
nm
nm
respect
substrat
hydrolysi
monitor
everi
second
measur
timedepend
increas
fluoresc
intens
use
tecan
safir
plate
reader
initi
rate
rfi
determin
linear
fit
data
convert
nm
describ
previous
avppvic
complex
incub
indic
concentr
nsc
mm
nacl
mm
trishcl
ph
ddm
mm
dtt
min
substrat
cbzleuargglyglynh
rhodamin
ad
increas
fluoresc
monitor
function
time
nci
compound
dissolv
neat
dmso
concentr
mm
coars
screen
eight
nci
compound
tabl
perform
avppvic
complex
incub
mm
nacl
mm
trishcl
ph
ddm
mm
dtt
nci
compound
min
enzym
activ
assay
fluorogen
substrat
cbzleuargglyglynh
rhodamin
inhibit
avp
assay
way
except
min
incub
pvic
ad
follow
addit
min
incub
measur
enzym
activ
ic
valu
compound
avp
avppvic
complex
determin
describ
coars
screen
enzym
inhibitor
except
nacl
concentr
buffer
mm
instead
mm
pvic
concentr
instead
ic
valu
determin
fit
doserespons
curv
fourparamet
logist
equat
equat
observ
initi
rate
v
min
minimum
initi
rate
v
max
maximum
initi
rate
inhibitor
concentr
n
hill
expon
avppvic
complex
incub
indic
concentr
nsc
mm
nacl
mm
trishcl
ph
ddm
mm
dtt
min
four
differ
concentr
substrat
cbzleuargglyglynh
rhodamin
ad
enzym
activ
assay
initi
rate
data
enter
sigmaplot
kinet
modul
jandel
scientif
analyz
variou
inhibit
model
best
fit
model
competit
inhibit
k
concentr
cbzleuargglyglynh
trypsin
pm
incub
increas
amount
compound
nsc
ten
minut
mm
hepe
ph
mm
cacl
enzym
activ
measur
monitor
rate
substrat
hydrolysi
ileproargnh
rhodamin
function
time
rate
normal
rate
absenc
inhibitor
report
activ
similar
assay
perform
papain
follow
except
concentr
papain
assay
buffer
mm
sodium
acet
ph
mm
dtt
substrat
pheargnh
rhodamin
comparison
structur
inact
avp
structur
activ
avppvic
complex
structur
reveal
number
differ
could
consid
target
drug
interact
fig
inspect
surfac
avppvic
complex
indic
nand
ctermini
pvic
bound
pocket
fig
compar
site
region
surfac
avp
structur
ntermin
bind
pocket
pvic
abbrevi
ntpocket
fulli
form
fig
ctermin
bind
pocket
pvic
abbrevi
ctpocket
therefor
must
induc
upon
bind
pvic
predict
drug
bind
ntpocket
would
prevent
bind
pvic
avp
henc
prevent
activ
avp
see
ntpocket
legitim
druggabl
site
mutat
ntermin
amino
acid
pvic
ala
k
bind
wildtyp
pvic
avp
k
mutant
least
order
magnitud
higher
therefor
pocket
legitim
site
structurebas
drug
design
ntpocket
avp
yield
sever
hundr
potenti
inhibitor
highest
energi
score
rank
hit
identifi
dock
compound
nsc
fig
favor
bind
pose
predict
ntpocket
shown
fig
fig
time
also
use
dock
find
ligand
predict
bind
activ
site
region
avppvic
complex
fig
use
ident
paramet
dock
notic
nsc
among
top
hit
predict
bind
pose
nsc
activ
site
avppvic
complex
shown
fig
fig
test
nsc
inhibitor
avp
avp
incub
differ
concentr
compound
pvic
cbzleuargglyglynh
rhodamin
ad
rate
substrat
hydrolysi
determin
data
complex
difficult
interpret
possibl
compound
bind
one
site
avp
data
shown
also
test
nsc
inhibitor
avppvic
complex
expect
predict
inhibitor
profil
compound
abl
bind
ntpocket
incub
differ
concentr
compound
enzym
ad
fluorogen
substrat
cbzleuargglyglynh
rhodamin
measur
rate
substrat
hydrolysi
clearli
compound
inhibit
avppvic
complex
fig
ic
tabl
test
nsc
promiscu
inhibitor
found
inhibit
activ
trypsin
data
shown
dock
pose
nsc
indic
signific
portion
compound
interact
avp
also
molecular
weight
slightli
high
initi
substructur
search
nci
repositori
found
compound
structur
relat
nsc
compound
among
compound
use
dock
analysi
structur
shown
tabl
essenti
compound
deriv
acetamidophenyl
sulfonylphenylacetamid
test
compound
inhibit
avp
avppvic
complex
four
compound
found
inhibit
either
activ
avp
activ
avppvic
complexesnsc
nsc
nsc
nsc
two
compound
nsc
nsc
effect
inhibitor
structur
nsc
similar
nsc
nsc
piperazinebas
cyclic
join
two
acetamidophenyl
sulfonylphenyl
acetamid
nsc
acetamid
moieti
derivat
cyclohexylcyclohexamin
sinc
nsc
predict
bind
ntpocket
avp
activ
site
avppvic
complex
one
might
expect
nsc
would
bind
site
data
shown
fig
consist
predict
two
site
ic
valu
avp
differ
ic
valu
avppvic
complex
tabl
sinc
nsc
predict
bind
activ
site
avppvic
complex
one
might
predict
nsc
would
competit
inhibitor
data
present
form
dixon
plot
fig
indic
nsc
inde
competit
inhibitor
avppvic
complex
k
tabl
similar
set
experi
done
avp
result
indic
mix
inhibit
k
fig
tabl
specif
nsc
avp
avppvic
complex
first
determin
whether
nsc
inhibit
trypsin
canon
serin
proteinas
concentr
nsc
concentr
would
inhibit
avp
avppvic
complex
inhibit
observ
fig
result
also
indic
nsc
promiscu
inhibitor
compound
bind
aggreg
anyth
therebi
gener
fals
posit
next
determin
whether
nsc
inhibit
canon
cystein
proteinas
papain
concentr
nsc
k
avp
inhibit
observ
fig
adenoviru
infect
two
form
avp
present
one
earli
one
late
avp
initi
synthes
inact
form
ntpocket
nterminu
pvic
bind
druggabl
target
compound
bind
prevent
pvic
bind
thu
inhibit
activ
enzym
parenthet
structur
ntpocket
avp
avppvic
complex
one
reason
avp
inact
activ
site
structur
differ
avppvic
activ
form
enzym
thu
activ
site
avp
consid
drug
howev
druggabl
site
avppvic
complex
drug
bind
activ
site
avppvic
complex
may
interfer
substrat
bind
therebi
affect
activ
enzym
dock
studi
reveal
compound
predict
bind
ntpocket
avp
activ
site
avppvic
complex
compound
inhibit
enzym
search
structur
variant
lead
inhibitor
identifi
two
even
effect
compound
compound
predict
bind
two
differ
site
one
avp
avpvic
complex
may
identifi
compound
inhibit
crucial
step
earli
infect
crucial
step
late
infect
compound
like
nsc
deriv
potenti
uniqu
antivir
agent
viru
may
difficulti
becom
resist
two
site
proteinas
predict
bind
nsc
ntpocket
activ
site
end
amino
acid
long
activ
path
two
bind
site
quit
far
minimum
two
mutat
may
requir
viru
becom
resist
probabl
two
independ
mutat
occur
specif
site
within
base
dna
molecul
quit
low
secondli
two
bind
site
connect
activ
path
mutat
lead
resist
one
site
may
affect
function
activ
path
lead
site
therebi
decreas
probabl
resist
aris
even
unlik
combin
therapi
instead
two
compound
interact
two
differ
site
one
compound
interact
two
differ
site
appar
specif
nsc
surpris
concentr
higher
would
inhibit
avp
avppvic
complex
compound
inhibit
trypsin
papain
result
surpris
crystal
structur
avppvic
complex
indic
four
amino
acid
involv
catalysi
ident
posit
papain
howev
examin
nsc
dock
activ
site
avppvic
complex
structur
align
papain
structur
activ
site
sever
region
within
activ
site
groov
predict
interact
nsc
adenoviru
proteinas
absent
papain
activ
site
may
origin
appar
select
nsc
much
need
done
character
inhibitor
especi
import
would
structur
cocryst
inhibitor
enzym
see
bind
pose
predict
dock
aid
design
addit
compound
test
least
howev
molecul
provid
scaffold
build
specif
second
gener
inhibitor
pvi
precursor
protein
vi
pvic
acid
peptid
cterminu
adenoviru
precursor
protein
pvi
ntpocket
pocket
surfac
avp
ntermin
residu
pvic
interact
avp
ctpocket
induc
pocket
surfac
avppvic
complex
ctermin
residu
pvic
interact
avp
rfi
rel
fluoresc
intens
numer
surfac
region
avp
identifi
potenti
druggabl
site
lead
compound
identifi
predict
interact
two
differ
druggabl
site
structur
deriv
lead
compound
effect
avp
structur
deriv
exhibit
select
inhibit
trypsin
papain
surfac
map
avp
reveal
potenti
drug
target
surfac
area
avp
contain
potenti
target
proteinas
inhibitor
molecular
surfac
avp
white
amino
acid
residu
involv
regul
enzym
activ
shown
color
activ
site
region
green
pvic
bind
region
pink
dna
bind
region
blue
residu
common
pvic
dna
bind
yellow
remaind
activ
pathway
red
predict
bind
pose
nsc
ntpocket
avp
activ
site
avppvic
complex
bind
nsc
ntpocket
avp
nsc
carbon
magenta
nitrogen
blue
sulfur
orang
oxygen
red
surfac
red
contain
amino
acid
residu
within
nsc
b
bind
nsc
activ
site
avppvic
complex
nsc
carbon
yellow
nitrogen
blue
sulfur
orang
oxygen
red
two
amino
acid
involv
catalysi
color
green
surfac
white
contain
amino
acid
residu
within
nsc
assay
potenti
second
gener
proteinas
inhibitor
coars
screen
nci
compound
whose
structur
shown
tabl
inhibit
assay
describ
experiment
procedur
initi
rate
enzym
activ
normal
initi
rate
absenc
inhibitor
plot
graph
comparison
control
activ
avp
gray
avppvic
complex
black
absenc
inhibitor
b
ic
valu
inhibit
avp
avppvic
complex
nsc
assay
perform
describ
experiment
procedur
ic
valu
avp
avppvic
complex
avp
avppvic
complex
c
competit
inhibit
avppvic
complex
nsc
avppvic
complex
incub
indic
concentr
nsc
min
four
differ
concentr
substrat
ad
enzym
activ
assay
describ
experiment
procedur
data
present
dixon
plot
yield
k
concentr
cbzleuargglyglynh
select
nsc
assay
trypsin
canon
serin
proteinas
papain
canon
cystein
proteinas
inhibit
assay
describ
experiment
procedur
rate
substrat
hydrolysi
normal
rate
absenc
inhibitor
report
activ
trypsin
papain
